Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients

OBJECTIVE: The safety of dendritic cells to selectively suppress autoimmunity, especially in type 1 diabetes, has never been ascertained. We investigated the safety of autologous dendritic cells, stabilized into an immunosuppressive state, in established adult type 1 diabetic patients. RESEARCH DESI...

Descripción completa

Detalles Bibliográficos
Autores principales: Giannoukakis, Nick, Phillips, Brett, Finegold, David, Harnaha, Jo, Trucco, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161299/
https://www.ncbi.nlm.nih.gov/pubmed/21680720
http://dx.doi.org/10.2337/dc11-0472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161299/
https://www.ncbi.nlm.nih.gov/pubmed/21680720
http://dx.doi.org/10.2337/dc11-0472

Ejemplares similares